Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;62(4):316-324.
Epub 2016 Sep 7.

Glutathione in the Treatment of Liver Diseases: Insights From Clinical Practice

Affiliations
  • PMID: 27603810
Review

Glutathione in the Treatment of Liver Diseases: Insights From Clinical Practice

Rodolfo Sacco et al. Minerva Gastroenterol Dietol. .

Abstract

Liver diseases markedly contribute to the global burden of mortality and morbidity. The pathogenesis of alcohol- and non-alcohol-induced liver diseases is complex, and many factors have been described to contribute to the progressive loss of liver functions, including the over-generation of reactive oxygen species. Glutathione (GSH) is the most important low-molecular-weight antioxidant synthesized in cells, as it is a reducing molecule which can react to oxygen species by neutralizing the unpaired electrons that make them highly reactive and dangerous. ROS over-production impairs the intracellular GSH homeostasis, leading to GSH deficiency, a pathophysiological hallmark in alcoholic and non-alcoholic liver diseases.Judging on the basis of the evidence obtained from experimental research and previous clinical studies, GSH administration seems to be a promising strategy to recover oxidative stress-induced liver damages in alcoholic and non-alcoholic liver diseases.

Similar articles

See all similar articles

Cited by 5 articles

MeSH terms

LinkOut - more resources

Feedback